Robert Roškar

1.8k total citations
81 papers, 1.4k citations indexed

About

Robert Roškar is a scholar working on Molecular Biology, Pharmaceutical Science and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Robert Roškar has authored 81 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Pharmaceutical Science and 14 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Robert Roškar's work include Analytical Chemistry and Chromatography (10 papers), Pharmaceutical and Antibiotic Environmental Impacts (10 papers) and Drug Solubulity and Delivery Systems (9 papers). Robert Roškar is often cited by papers focused on Analytical Chemistry and Chromatography (10 papers), Pharmaceutical and Antibiotic Environmental Impacts (10 papers) and Drug Solubulity and Delivery Systems (9 papers). Robert Roškar collaborates with scholars based in Slovenia, Switzerland and Italy. Robert Roškar's co-authors include Žane Temova Rakuša, Vojko Kmetec, Jurij Trontelj, Albin Kristl, Petra Kocbek, Julijana Kristl, Aleš Mrhar, Odon Planinšek, Zoran Lavrič and Iztok Grabnar and has published in prestigious journals such as The Science of The Total Environment, Food Chemistry and Environmental Pollution.

In The Last Decade

Robert Roškar

77 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Roškar Slovenia 22 244 223 185 175 168 81 1.4k
Gül Özhan Türkiye 23 264 1.1× 125 0.6× 163 0.9× 182 1.0× 91 0.5× 103 1.6k
Beata Stanisz Poland 15 156 0.6× 232 1.0× 100 0.5× 241 1.4× 118 0.7× 68 1.5k
Vuanghao Lim Malaysia 29 474 1.9× 192 0.9× 303 1.6× 373 2.1× 158 0.9× 138 2.4k
Alexandra Fürtös Canada 17 440 1.8× 93 0.4× 233 1.3× 104 0.6× 208 1.2× 40 1.4k
Shufen Cui China 17 209 0.9× 277 1.2× 63 0.3× 287 1.6× 251 1.5× 27 1.1k
Lei Yin China 18 271 1.1× 181 0.8× 115 0.6× 209 1.2× 48 0.3× 83 1.1k
Jolanta Flieger Poland 25 361 1.5× 296 1.3× 129 0.7× 373 2.1× 61 0.4× 118 2.6k
Muhammad Ali Sheraz Pakistan 21 192 0.8× 210 0.9× 68 0.4× 189 1.1× 125 0.7× 71 1.3k
Mingli Ye China 17 352 1.4× 243 1.1× 158 0.9× 293 1.7× 155 0.9× 59 1.4k
Ashish Dwivedi India 26 340 1.4× 136 0.6× 102 0.6× 172 1.0× 35 0.2× 71 1.4k

Countries citing papers authored by Robert Roškar

Since Specialization
Citations

This map shows the geographic impact of Robert Roškar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Roškar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Roškar more than expected).

Fields of papers citing papers by Robert Roškar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Roškar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Roškar. The network helps show where Robert Roškar may publish in the future.

Co-authorship network of co-authors of Robert Roškar

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Roškar. A scholar is included among the top collaborators of Robert Roškar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Roškar. Robert Roškar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roškar, Robert, et al.. (2025). Advanced analytical approach for the determination of NDELA and twelve other N-nitrosamines in cosmetic products. Microchemical Journal. 218. 115521–115521.
2.
Roškar, Robert, et al.. (2025). Additive effects of the new viscosity-reducing and stabilizing excipients for monoclonal antibody formulation. International Journal of Pharmaceutics. 674. 125451–125451. 3 indexed citations
5.
Podobnik, Boris, Aleš Jerin, Joško Osredkar, et al.. (2024). N-Acetylcysteine Ineffective in Alleviating Hangover from Binge Drinking: A Clinical Study. Toxics. 12(8). 585–585. 1 indexed citations
6.
Roškar, Robert, et al.. (2024). The Incorporated Drug Affects the Properties of Hydrophilic Nanofibers. Nanomaterials. 14(11). 949–949. 7 indexed citations
7.
Roškar, Robert, et al.. (2024). Enteric Coated Pellets with Lactoferrin for Oral Delivery: Improved Shelf Life of the Product. Pharmaceutics. 17(1). 23–23.
8.
Rakuša, Žane Temova & Robert Roškar. (2024). Content-Related Quality Control of Water- and Fat-Soluble Vitamins in Fortified Non-Alcoholic Beverages. Nutrients. 16(22). 3872–3872. 1 indexed citations
10.
Roškar, Robert, et al.. (2022). Use of Retinoids in Topical Antiaging Treatments: A Focused Review of Clinical Evidence for Conventional and Nanoformulations. Advances in Therapy. 39(12). 5351–5375. 61 indexed citations
11.
Rakuša, Žane Temova, et al.. (2022). Evaluation of the Stability of Hydrocortisone Sodium Succinate in Solutions for Parenteral Use by a Validated HPLC-UV Method. Acta chimica slovenica. 69(4). 796–802. 3 indexed citations
12.
Žakelj, Simon, et al.. (2020). Suitability and functional characterization of two Calu-3 cell models for prediction of drug permeability across the airway epithelial barrier. International Journal of Pharmaceutics. 585. 119484–119484. 34 indexed citations
13.
Zupančič, Špela, et al.. (2019). The potential of nanofibers to increase solubility and dissolution rate of the poorly soluble and chemically unstable drug lovastatin. International Journal of Pharmaceutics. 573. 118809–118809. 33 indexed citations
14.
Roškar, Robert, et al.. (2017). A novel LC–MS/MS method for the simultaneous quantification of topiramate and its main metabolites in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 138. 180–188. 11 indexed citations
15.
Bockstal, Pieter-Jan Van, Robert Roškar, Tamás Sovány, et al.. (2016). Comparison of metoprolol tartrate multiple-unit lipid matrix systems produced by different technologies. European Journal of Pharmaceutical Sciences. 88. 233–245. 10 indexed citations
16.
Baumgartner, Saša, Robert Roškar, Odon Planinšek, et al.. (2015). Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs. European Journal of Pharmaceutical Sciences. 75. 101–113. 140 indexed citations
17.
Roškar, Robert, et al.. (2011). Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC–MS/MS assay. Toxicology. 292(1). 33–41. 34 indexed citations
18.
Roškar, Robert, et al.. (2011). Determination of raloxifene and its glucuronides in human urine by liquid chromatography–tandem mass spectrometry assay. Journal of Chromatography B. 879(23). 2323–2331. 25 indexed citations
19.
Roškar, Robert, et al.. (2007). Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations. International Journal of Pharmaceutics. 342(1-2). 145–151. 19 indexed citations
20.
Kmetec, Vojko & Robert Roškar. (2003). HPLC determination of tramadol in human breast milk. Journal of Pharmaceutical and Biomedical Analysis. 32(4-5). 1061–1066. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026